Enterprise Financial Services Corp (EFSC)’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-3,014
Closed -$208K – 167
2025
Q2
$208K Buy
+3,014
New +$205K 0.11% 151
2025
Q1
– Sell
-2,930
Closed -$252K – 152
2024
Q4
$252K Buy
2,930
+1
+0% +$108 0.14% 123
2024
Q3
$349K Sell
2,929
-276
-9% -$36.8K 0.2% 99
2024
Q2
$457K Buy
3,205
+5
+0.2% +$663 0.28% 77
2024
Q1
$411K Sell
3,200
-266
-8% -$31.7K 0.25% 86
2023
Q4
$359K Sell
3,466
-10
-0.3% -$989 0.22% 103
2023
Q3
$316K Buy
3,476
+90
+3% +$7.93K 0.22% 99
2023
Q2
$274K Buy
3,386
+44
+1% +$3.59K 0.17% 122
2023
Q1
$266K Sell
3,342
-348
-9% -$24.7K 0.17% 125
2022
Q4
$250K Buy
+3,690
New +$216K 0.17% 124
2022
Q3
– Sell
-3,784
Closed -$211K – 184
2022
Q2
$211K Buy
+3,784
New +$210K 0.04% 263
2021
Q4
– Sell
-400
Closed -$19K – 429
2021
Q3
$19K Sell
400
-1,468
-79% -$71K ﹤0.01% 316
2021
Q2
$78K Buy
1,868
+112
+6% +$4.34K 0.01% 315
2021
Q1
$59K Buy
1,756
+178
+11% +$6.34K 0.01% 374
2020
Q4
$55K Sell
1,578
-182
-10% -$6.29K 0.01% 367
2020
Q3
$61K Hold
1,760
– – 0.01% 349
2020
Q2
$58K Buy
1,760
+34
+2% +$1.08K 0.01% 348
2020
Q1
$52K Buy
1,726
+30
+2% +$893 0.01% 345
2019
Q4
$50K Hold
1,696
– – 0.01% 412
2019
Q3
$44K Buy
1,696
+206
+14% +$5.21K 0.01% 419
2019
Q2
$38K Sell
1,490
-144
-9% -$3.56K 0.01% 461
2019
Q1
$42K Buy
1,634
+518
+46% +$12.7K 0.01% 438
2018
Q4
$26K Sell
1,116
-126
-10% -$2.8K 0.02% 332
2018
Q3
$29K Hold
1,242
– – 0.02% 364
2018
Q2
$29K Sell
1,242
-184
-13% -$4.37K 0.01% 383
2018
Q1
$35K Buy
1,426
+386
+37% +$10.1K 0.02% 352
2017
Q4
$28K Hold
1,040
– – 0.01% 384
2017
Q3
$25K Buy
1,040
+36
+4% +$814 0.01% 400
2017
Q2
$22K Sell
1,004
-282
-22% -$5.69K 0.01% 427
2017
Q1
$22K Sell
1,286
-60
-4% -$1.04K 0.01% 441
2016
Q4
$24K Buy
1,346
+182
+16% +$3.3K 0.01% 408
2016
Q3
$24K Hold
1,164
– – 0.01% 385
2016
Q2
$31K Hold
1,164
– – 0.02% 316
2016
Q1
$32K Sell
1,164
-104
-8% -$2.79K 0.02% 315
2015
Q4
$37K Buy
1,268
+88
+7% +$2.44K 0.02% 301
2015
Q3
$32K Sell
1,180
-212
-15% -$6K 0.02% 301
2015
Q2
$38K Hold
1,392
– – 0.02% 281
2015
Q1
$37K Buy
1,392
+112
+9% +$2.58K 0.02% 304
2014
Q4
$27K Hold
1,280
– – 0.02% 367
2014
Q3
$30K Hold
1,280
– – 0.02% 344
2014
Q2
$30K Hold
1,280
– – 0.02% 361
2014
Q1
$29K Hold
1,280
– – 0.02% 353
2013
Q4
$24K Hold
1,280
– – 0.01% 372
2013
Q3
$22K Buy
1,280
+130
+11% +$2.19K 0.01% 364
2013
Q2
$18K Buy
+1,150
New +$19.1K 0.01% 348

Other funds holding NVO

Enterprise Financial Services Corp (EFSC)'s NVO Position: Q3 2025 in Review

Enterprise Financial Services Corp (EFSC) sold out of Novo Nordisk (NVO) in Q3 2025, closing a stake of 3,014 shares — an estimated $208K sold.

Enterprise Financial Services Corp (EFSC) first reported a position in NVO in Q2 2013 and held it in 45 quarters. The position peaked at $457K in Q2 2024. 1,400 funds tracked by Wall St. Rank hold NVO as of Q3 2025.

  • Enterprise Financial Services Corp (EFSC) reported no remaining Novo Nordisk position as of Q3 2025 after selling out during the quarter.
  • Enterprise Financial Services Corp (EFSC) sold 3,014 Novo Nordisk shares in Q3 2025, an estimated $208K.
  • Enterprise Financial Services Corp (EFSC) first reported a position in Novo Nordisk in Q2 2013 and held it in 45 quarters.
  • Enterprise Financial Services Corp (EFSC)'s Novo Nordisk position peaked at $457K in Q2 2024.
  • 1,400 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2025.

Based on Enterprise Financial Services Corp (EFSC)'s 13F filing for Q3 2025, filed 15 Oct 2025.